Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F7TR
|
|||
| Former ID |
DIB010185
|
|||
| Drug Name |
Autologous skeletal myoblast therapy
|
|||
| Synonyms |
Autologous skeletal myoblast therapy (heart failure); Autologous skeletal myoblast therapy (heart failure), ACTC; Autologous skeletal myoblast therapy (heart failure), Advanced Cell Technology; Autologous skeletal myoblast therapy (myocardial infarctoin), Mytogen; Autologous stem cell therapy (heart failure), ACTC; Autologous stem cell therapy (myocardial infarction), Mytogen
Click to Show/Hide
|
|||
| Indication | Cardiac failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9] | Phase 2/3 | [1] | |
| Company |
Mytogen Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases. Curr Opin Mol Ther. 2008 December; 10(6): 611-621. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.